Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mariam S. Mukhtar"'
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 6, Pp 346-352 (2024)
Background: The medical treatment of ulcerative colitis (UC) includes the use of biological agents such as vedolizumab, a gut-selective alpha4beta7 (ɑ4β7) antagonist. The mechanism of action of vedolizumab involves interfering with leukocyte traffi
Externí odkaz:
https://doaj.org/article/7cb61b6eb91a49498f9fae8d45141c65
Autor:
Mariam S. Mukhtar, Mahmoud H. Mosli
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 30, Iss 3, Pp 126-137 (2024)
Ulcerative colitis (UC) is a chronic autoimmune inflammatory disease that affects the colon, leading to symptoms of bloody diarrhea, abdominal cramps, and urgency. The treatment of UC has evolved over the past few decades from locally active anti-inf
Externí odkaz:
https://doaj.org/article/d3225941593044529ae84552233e3e2b
Autor:
Parul Tandon, Mariam S Mukhtar, Kate Lee, Sharyle Fowler, Alain Bitton, M Ellen Kuenzig, Gilaad G. Kaplan, Lesley A. Graff, Laura E Targownik, Eric I Benchimol, Joseph W. Windsor, Jennifer Jones, Charles N. Bernstein, James Guoxian Huang
Publikováno v:
Journal of the Canadian Association of Gastroenterology
There has been a dramatic rise in mental health difficulties during the coronavirus disease 2019 (COVID-19) pandemic. While young adults have the lowest risk of hospitalization and mortality due to COVID-19, they have been identified as being at high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edd3e8e6b709c073361451599036248
https://doi.org/10.1093/jcag/gwab031
https://doi.org/10.1093/jcag/gwab031
Autor:
Joseph W. Windsor, Jennifer Jones, Charles N. Bernstein, Parul Tandon, Alain Bitton, Harminder Singh, M Ellen Kuenzig, Gilaad G. Kaplan, Mariam S Mukhtar, Kate Lee, James Guoxian Huang, Eric I Benchimol, Geoffrey C. Nguyen, Laura E Targownik, Sanjay K. Murthy
Publikováno v:
Journal of the Canadian Association of Gastroenterology
The risk of hospitalization and death from Coronavirus disease-19 (COVID-19) increases with age. The extreme elderly have been particularly vulnerable, with those above the age of 80 having a case-fatality rate as high as 15%. Aging of the immune sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2063e19f4a11ace5ed2ff3bafb269eec
https://doi.org/10.1093/jcag/gwab025
https://doi.org/10.1093/jcag/gwab025
Autor:
Gilaad G. Kaplan, Parul Tandon, Kate Lee, Laura E Targownik, Mariam S Mukhtar, Alain Bitton, Remo Panaccione, M Ellen Kuenzig, James Guoxian Huang, Sanjay K. Murthy, Eric I Benchimol, Joseph W. Windsor, Jennifer Jones, Charles N. Bernstein, Peter L. Lakatos
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Inflammatory bowel disease (IBD) is a disease that results from dysregulation of the immune system and frequently requires medications that can affect the immune response to infections; therefore, it was imperative to quickly understand the risk of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e067da7a3cacdefbb86fd522396155f
https://doi.org/10.1093/jcag/gwab032
https://doi.org/10.1093/jcag/gwab032
Autor:
Alain Bitton, Eric I Benchimol, Charles N. Bernstein, M Ellen Kuenzig, Jennifer Jones, Joseph W. Windsor, James Guoxian Huang, Parul Tandon, Laura E Targownik, Mariam S Mukhtar, Reena Khanna, Sanjay K. Murthy, Kate Lee, Gilaad G. Kaplan, Stephanie Coward
Publikováno v:
Journal of the Canadian Association of Gastroenterology
At the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there were many unknowns: transmission vectors of the virus, appropriate intervention strategies and if being immunocompromised due to inflammatory bowel disease (IBD), for example
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd07d19af9cf2b4c1c9380761f3e6f76
https://doi.org/10.1093/jcag/gwab029
https://doi.org/10.1093/jcag/gwab029
Autor:
Matthew W Carroll, James Guoxian Huang, Cynthia H. Seow, Alain Bitton, David R. Mack, Rose Geist, Gilaad G. Kaplan, Jennifer Jones, Kate Lee, Laura E Targownik, Charles N. Bernstein, Joseph W. Windsor, Sanjay K. Murthy, Parul Tandon, Mariam S Mukhtar, Eric I Benchimol, M Ellen Kuenzig, Anne M. Griffiths
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Coronavirus disease 2019 (COVID-19) in children with inflammatory bowel disease (IBD) typically results in a mild infection, similar to those without IBD. Children and adolescents have less severe manifestations of COVID-19 compared to older people,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9a565c965ac68cc275db0bb1ad047d
http://europepmc.org/articles/PMC8570420
http://europepmc.org/articles/PMC8570420
Autor:
Jennifer Jones, Kate Lee, Jean-Eric Ghia, Parul Tandon, Charles N. Bernstein, Mariam S Mukhtar, Deanna L. Gibson, Anne M. Griffiths, Cynthia H. Seow, Alain Bitton, James Guoxian Huang, M Ellen Kuenzig, Joseph W. Windsor, Sanjay K. Murthy, Remo Panaccione, Eric I Benchimol, Gilaad G. Kaplan, Laura E Targownik
Publikováno v:
Journal of the Canadian Association of Gastroenterology
The COVID-19 pandemic has ushered a globally focused vaccine development program that produced multiple successful vaccines within a year. Four SARS-CoV-2 vaccines have been approved for use in Canada, using two different technologies, all of which h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755e37add13e7dc9349af7b81ab6473c
http://europepmc.org/articles/PMC8570416
http://europepmc.org/articles/PMC8570416
Autor:
Alain Bitton, Geoffrey C. Nguyen, M Ellen Kuenzig, Charles N. Bernstein, Sanjay K. Murthy, John Marshall, Parul Tandon, Laura E Targownik, James Guoxian Huang, Eric I Benchimol, Mariam S Mukhtar, Gilaad G. Kaplan, Jennifer Jones, Joseph W. Windsor
Publikováno v:
Journal of the Canadian Association of Gastroenterology
The SARS-CoV-2 pandemic has had a profound impact on inflammatory bowel disease (IBD) health care delivery. The implementation of necessary public health restrictions has restricted access to medications, procedures and surgeries throughout the pande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee612a946d4198e5097b40430521f7f0
https://pubmed.ncbi.nlm.nih.gov/34755041
https://pubmed.ncbi.nlm.nih.gov/34755041
Autor:
Alain Bitton, Cynthia H. Seow, David R. Mack, Parul Tandon, Mariam S Mukhtar, Eric I Benchimol, Peter L. Lakatos, Sandra Zelinsky, Jennifer Jones, Laura E Targownik, Lisa Barrett, John Marshall, Kate Lee, Usha Chauhan, Anne M. Griffiths, Harminder Singh, Geoffrey C. Nguyen, Sharyle Fowler, Rose Geist, M Ellen Kuenzig, Matthew W Carroll, Gilaad G. Kaplan, Deanna L. Gibson, Remo Panaccione, Sanjay K. Murthy, Joseph W. Windsor, Lesley A. Graff, Jean-Eric Ghia, Reena Khanna, James Guoxian Huang, Charles N. Bernstein, Stephanie Coward
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Persons with inflammatory bowel disease (IBD) make up more than 0.75% of the Canadian population in 2021. Early in the COVID-19 pandemic, individuals with IBD, particularly those on immunosuppressive therapies, were concerned that their health status
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d81b068a9d68e1d896472bb94803165
https://pubmed.ncbi.nlm.nih.gov/34755033
https://pubmed.ncbi.nlm.nih.gov/34755033